Document is current
Any future updates will be listed below
-
Authors
Hwang-Bo, Jeon
Kim, Byungwook
Park, Dae Won
Lee, Yeong-Geun
Kwon, Jeong Eun
Chung, Jae-Yong
Kang, Se Chan http://orcid.org/0000-0003-0790-2237
-
Clinical Trials BETA
Clinical trials referenced in this document:
kct0006066 at Clinical Research Information Service, Republic of KoreaDocuments that mention this clinical trial
Safety, tolerability of ES16001, a novel varicella zoster virus reactivation inhibitor, in healthy adults
https://doi.org/10.1186/s40001-021-00565-z
-
Funding
Funding for this research was provided by:
Genencell Co. Ltd
- License Information
-
More Information
Article History
Received: 16 July 2021
Accepted: 3 August 2021
First Online: 12 August 2021
Declarations
:
: This clinical trial (GNC_PT1_2018001) was reviewed and approved by the Ethics Committee of Seoul National University Bundang Hospital, and was performed in accordance with Korean Good Clinical Practice (KGCP). This study is based on the Helsinki Declaration and was conducted with the rights and welfare of the subjects in mind. Prior to screening, all participants provided written informed consent to participate in the study after having been informed about the nature and purpose of the study and participation/withdrawal conditions.
: Not applicable.
: The authors declare that they have no competing interests.
